AbbVievsBeOne Medicines

ABBV and ONC stock compared: price, dividend, valuation and results, from SEC filings.

ONC

BeOne Medicines Ltd.

$390.94

Value $43.4B

-2.19%
ONC's page

AbbVie (ABBV) has a market value of $506B and BeOne Medicines (ONC) $43.4B. Over the last year, with dividends, ABBV moved +26.6% and ONC +10.5%. The P/E is 49.2 for ABBV and 47.4 for ONC. Dividend yield: ABBV 2.42%, ONC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$506B

    ONC$43.4B

    ABBV is 12 times ONC

  • Revenue, 12 months

    ABBV$66.0B

    ONC$6.6B

    ABBV is 10.0 times ONC

  • Net income, 12 months

    ABBV$10.3B

    ONC$916M

    ABBV is 11 times ONC

  • Operating margin

    ABBV32.2%

    ONC17.8%

    14.4 points apart

  • ROIC

    ABBV25.7%

    ONC16.2%

    9.5 points apart

  • P/E

    ABBV49.2

    ONC47.4

    About the same

  • Dividend yield

    ABBV2.4%

    ONC0.0%

    2.4 points apart

  • 5-year return

    ABBV+194.4%

    ONC+7.2%

    187.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+194.4%

ONC+7.2%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsONCWith dividends
1 year since November 19, 2025+26.6%Price +22.9%+10.5%Price +10.5%
3 years since November 20, 2023+128.8%+31.8% a yearPrice +106.9%+108.1%+27.7% a yearPrice +108.1%
5 years since November 19, 2021+194.4%+24.1% a yearPrice +146.2%+7.2%+1.4% a yearPrice +7.2%
10 years since November 21, 2016+612.1%+21.7% a yearPrice +373.7%+1,140.7%+28.6% a yearPrice +1,140.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieONCBeOne Medicines

Valuation

ABBVONC
Valuation
Price$286.20$390.94
Market value$506B$43.4B
Enterprise value (EV)$576B–
P/E49.247.4
P/E, 5-year median57.0–
P/B–7.5
EV/EBIT27.1–
Free cash flow yield3.7%3.3%

Results and growth

ABBVONC
Results and growth
Revenue, 12 months$66.0B$6.6B
Net income, 12 months$10.3B$916M
Free cash flow, 12 months$18.9B$1.4B
Earnings per share, 12 months$5.81$7.80
Revenue growth, year on year8.6%40.2%
Revenue growth a year, past+5.9%over 5 years+76.9%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVONC
Margins and returns on capital
Gross margin73.7%89.4%
Operating margin32.2%17.8%
Net margin15.7%13.9%
ROIC25.7%16.2%
ROE–18.9%

Balance sheet

ABBVONC
Balance sheet
Cash$10.8B$5.8B
Total debt$80.9B–
Net debt / EBITDA3.2–
Interest cover7.1×8.3×

Dividends and buybacks

ABBVONC
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.6%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or ONC

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or BeOne Medicines?

By market value, AbbVie ($506B) is about 11.7 times BeOne Medicines ($43.4B), at today's prices.

How did ABBV and ONC stock do over the last 10 years?

Since November 21, 2016, ABBV's price moved +373.7% and ONC's +1,140.7%. With dividends: ABBV +612.1% (+21.7% a year), ONC +1,140.7% (+28.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or ONC?

The dividend yield at today's price is 2.42% for AbbVie and none for BeOne Medicines. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and ONC?

At today's price, the P/E is 49.2 for ABBV and 47.4 for ONC. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or BeOne Medicines?

Over the last twelve months, the net margin was 15.7% for AbbVie and 13.9% for BeOne Medicines, and the operating margin 32.2% and 17.8%. Revenue was $66.0B and $6.6B.

Which is the better investment, AbbVie or BeOne Medicines?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.